ES2171531T3 - Derivados de carbamoilmetilurea. - Google Patents
Derivados de carbamoilmetilurea.Info
- Publication number
- ES2171531T3 ES2171531T3 ES95907849T ES95907849T ES2171531T3 ES 2171531 T3 ES2171531 T3 ES 2171531T3 ES 95907849 T ES95907849 T ES 95907849T ES 95907849 T ES95907849 T ES 95907849T ES 2171531 T3 ES2171531 T3 ES 2171531T3
- Authority
- ES
- Spain
- Prior art keywords
- optionally replaced
- cck
- cyclealkyl
- receptors
- receivers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002131 composite material Substances 0.000 abstract 2
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical group [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 150000003973 alkyl amines Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Paints Or Removers (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
SE PRESENTA UN COMPUESTO DE LA FORMULA (I) EN LA QUE R1 ES UN ATOMO DE HIDROGENO O UN ALQUILO INFERIOR; R2 ES UN ALCOXIDO INFERIOR, ALQUILAMINO, CICLOALQUILO INFERIOR, FENILO OPCIONALMENTE SUSTITUIDO POR O UN GRUPO HETEROCICLICO OPCIONALMENTE SUSTITUIDO; R3 ES FENILO OPCIONALMENTE SUSTITUIDO; R4 ES UN FENILO OPCIONALMENTE SUSTITUIDO, CICLOALQUILO OPCIONALMENTE SUSTITUIDO, ALQUILO OPCIONALMENTE SUSTITUIDO O UN GRUPO HETEROCICLICO OPCIONALMENTE SUSTITUIDO, TAMBIEN SE PRESENTAN LAS SALES FARMACOLOGICAMENTE ESTABLES DEL COMPUESTO, QUE TIENE UNA ALTA AFINIDAD PARA LOS RECEPTORES DE LA GASTRINA Y/O LOS RECEPTORES CCK-B PERO NO PARA LOS RECEPTORES CCK-A, Y ES UTIL PARA EL TRATAMIENTO DE LAS ENFERMEDADES ASOCIADAS CON LOS RECEPTORES DE LA GASTRINA Y CON LOS RECEPTORES CCK-B SIN INTRODUCIR LOS EFECTOS COLATERALES ASOCIADOS CON LOS RECEPTORES CCK-A.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1518994 | 1994-02-09 | ||
JP24155594 | 1994-10-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2171531T3 true ES2171531T3 (es) | 2002-09-16 |
Family
ID=26351304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95907849T Expired - Lifetime ES2171531T3 (es) | 1994-02-09 | 1995-02-07 | Derivados de carbamoilmetilurea. |
Country Status (17)
Country | Link |
---|---|
US (1) | US5739162A (es) |
EP (1) | EP0739903B1 (es) |
CN (1) | CN1145074A (es) |
AT (1) | ATE212356T1 (es) |
AU (1) | AU691565B2 (es) |
BR (1) | BR9506763A (es) |
CA (1) | CA2181986A1 (es) |
DE (1) | DE69525145T2 (es) |
ES (1) | ES2171531T3 (es) |
FI (1) | FI963122A0 (es) |
HU (1) | HU219913B (es) |
MX (1) | MX9603171A (es) |
NO (1) | NO963307L (es) |
PT (1) | PT739903E (es) |
RU (1) | RU2134684C1 (es) |
TW (1) | TW294653B (es) |
WO (1) | WO1995021856A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5804560A (en) * | 1995-01-06 | 1998-09-08 | Sibia Neurosciences, Inc. | Peptide and peptide analog protease inhibitors |
CN1197451A (zh) * | 1995-08-07 | 1998-10-28 | 盐野义制药株式会社 | 氨基甲酰基甲基脲衍生物的制备方法 |
US9428549B2 (en) * | 2013-07-16 | 2016-08-30 | Allegran, Inc. | Derivatives of N-urea substituted amino acids as formyl peptide receptor modulators |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0166355A2 (en) * | 1984-06-26 | 1986-01-02 | Merck & Co. Inc. | Substituted aminophenyl compounds and acylaminophenyl compounds and pharmaceutical compositions containing them |
JPH05506643A (ja) * | 1990-02-09 | 1993-09-30 | ローン―プーラン・ロレ・ソシエテ・アノニム | N―フエニル―n―アセトアミドグリシンアミド類、それらの製造およびそれらを含有する薬物 |
FR2659334B1 (fr) * | 1990-03-07 | 1992-05-15 | Rhone Poulenc Sante | Derives de n-phenyl glycinamide, leur preparation et les medicaments les contenant. |
FR2667864B2 (fr) * | 1990-03-07 | 1994-08-05 | Rhone Poulenc Sante | Derives de n-phenyl glycinamides, leur preparation et les medicaments les contenant. |
FR2659653B1 (fr) * | 1990-03-13 | 1992-05-22 | Rhone Poulenc Sante | Derives de l'uree, leur preparation et les medicaments les contenant. |
-
1995
- 1995-02-07 CA CA002181986A patent/CA2181986A1/en not_active Abandoned
- 1995-02-07 RU RU96119576A patent/RU2134684C1/ru active
- 1995-02-07 HU HU9602187A patent/HU219913B/hu not_active IP Right Cessation
- 1995-02-07 CN CN95192442A patent/CN1145074A/zh active Pending
- 1995-02-07 MX MX9603171A patent/MX9603171A/es unknown
- 1995-02-07 PT PT95907849T patent/PT739903E/pt unknown
- 1995-02-07 AU AU15905/95A patent/AU691565B2/en not_active Ceased
- 1995-02-07 ES ES95907849T patent/ES2171531T3/es not_active Expired - Lifetime
- 1995-02-07 BR BR9506763A patent/BR9506763A/pt not_active IP Right Cessation
- 1995-02-07 EP EP95907849A patent/EP0739903B1/en not_active Expired - Lifetime
- 1995-02-07 DE DE69525145T patent/DE69525145T2/de not_active Expired - Fee Related
- 1995-02-07 WO PCT/JP1995/000161 patent/WO1995021856A1/ja active IP Right Grant
- 1995-02-07 US US08/687,433 patent/US5739162A/en not_active Expired - Fee Related
- 1995-02-07 AT AT95907849T patent/ATE212356T1/de not_active IP Right Cessation
- 1995-02-08 TW TW084101068A patent/TW294653B/zh active
-
1996
- 1996-08-08 NO NO963307A patent/NO963307L/no not_active Application Discontinuation
- 1996-08-09 FI FI963122A patent/FI963122A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
PT739903E (pt) | 2002-05-31 |
AU1590595A (en) | 1995-08-29 |
EP0739903A4 (en) | 1998-07-08 |
AU691565B2 (en) | 1998-05-21 |
US5739162A (en) | 1998-04-14 |
DE69525145D1 (en) | 2002-03-14 |
HU219913B (hu) | 2001-09-28 |
CA2181986A1 (en) | 1995-08-17 |
RU2134684C1 (ru) | 1999-08-20 |
FI963122A (fi) | 1996-08-09 |
DE69525145T2 (de) | 2002-08-29 |
FI963122A0 (fi) | 1996-08-09 |
BR9506763A (pt) | 1997-10-07 |
HU9602187D0 (en) | 1996-10-28 |
CN1145074A (zh) | 1997-03-12 |
ATE212356T1 (de) | 2002-02-15 |
TW294653B (es) | 1997-01-01 |
NO963307D0 (no) | 1996-08-08 |
NO963307L (no) | 1996-10-09 |
EP0739903A1 (en) | 1996-10-30 |
MX9603171A (es) | 1997-03-29 |
HUT74950A (en) | 1997-03-28 |
WO1995021856A1 (fr) | 1995-08-17 |
EP0739903B1 (en) | 2002-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2093753T3 (es) | Derivados de estireno. | |
MX9205242A (es) | Compuestos heterociclicos que contienen nitrogeno triciclico fusionado. | |
ES2123149T3 (es) | Derivados de perhidroisoindol como antagonistas de la substancia p. | |
ES2053508T3 (es) | Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos. | |
ES2176252T3 (es) | Benzamidas sustituidas con fluoro-alcoxi y su utilizacion como agentes inhibidores de fosfodiesterasas de nucleotidos ciclicos. | |
EA200300323A1 (ru) | ПРОИЗВОДНЫЕ ГУАНИДИНОБЕНЗАМИДА (ВАРИАНТЫ), КОМПОЗИЦИЯ (ВАРИАНТЫ), СПОСОБ ЛЕЧЕНИЯ ОПОСРЕДОВАННОГО mc4-r ЗАБОЛЕВАНИЯ (ВАРИАНТЫ) | |
ES2163638T3 (es) | Nuevas n-(1-alquil-5-fenil-2,3,4,5-tetrahidro-1h-benzo(b)(1,5)diacepin-3-il)acetamidas. | |
SV2003000633A (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7 | |
PA8454601A1 (es) | Azetidinas | |
AR009145A1 (es) | Compuetos heterociclicos de guanidinilo utiles como agonistas de alfa-2 adrenoreceptores y composiciones farmaceuticas que los comprenden | |
DK0556329T3 (da) | Substituerede piperaziner som midler til behandling af centralnervesystemet | |
MX9203243A (es) | Oxazolidinonas y composiciones farmaceuticas que las contienen. | |
FI894061A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten , -disubstituoitujen N-sykloalkyylialkyylibentsyyliamiinien valmistamiseksi ja niiden synteesivälituotteita | |
NO943133D0 (no) | Benzodiazepinderivater egnet til bruk som CCK-reseptorantagonister | |
FI964045A (fi) | CCK:ta tai gastriinia säätelevä 5-heterosykli-1,5-bentsodiatsepiinejä | |
ES2171531T3 (es) | Derivados de carbamoilmetilurea. | |
FI970434A (fi) | Uudet 3-substituoidut 3H-2,3-bentsodiatsepiinijohdannaiset, niiden valmistus ja käyttö lääkkeenä | |
ES2069313T3 (es) | Utilizacion de derivados de tiazoloisoindolinona como medicamentos antiviricos. | |
AR027349A1 (es) | Derivados de amidas heterociclicas | |
UY26329A1 (es) | Antagonistas de los receptores de vitronectina | |
ES2167725T3 (es) | Procedimiento para la coloracion de material organico de alto peso molecular, y pigmentos policiclicos. | |
CR6503A (es) | Derivados de- 1-trifluorometil-4-hidroxi-7-piperidinil-aminometiclcromano | |
PT100001A (pt) | Novos derivados glicosilicos inibidores da gluco-hidrolase uteis como agentes antidiabeticos | |
AR032373A2 (es) | Intermediarios para preparar 3-(1-piperazinil)-1,2-benzoisotiazol. | |
DK0625982T3 (da) | 4-Oxo- og 4H-imidazo(5,1-c)(1,4)benzoxaziner anvendelige som benzodiazepinreceptor-bindemidler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 739903 Country of ref document: ES |